Literature DB >> 4260123

Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

T W Smith.   

Abstract

Antibodies with high affinity and specificity for the cardiac glycoside ouabain were raised in rabbits. The antigen used was a conjugate of ouabain linked through its rhamnose moiety to terminal alpha-amino groups of poly D,L alanyl-human serum albumin. Ouabain-specific antibodies were present as early as 3 wk, and rose steadily in titer over the initial 20-33 wk of immunization. Levels as high as 6.5 mg specific immunoglobulin per ml antiserum were reached in one rabbit at the end of 45 wk. The average intrinsic association constants for ouabain were 1.3 x 10(9) M(-1) and 1.6 x 10(9) M(-1) in antisera studied in detail, and there was evidence of restricted heterogeneity of binding site affinities. A high degree of specificity was demonstrated. Significant cross-reactivity occurred only with other cardioactive steroid compounds such as acetyl strophanthidin, digoxin, and digitoxin, while endogenous steroids did not cross-react even when present in 1000-fold excess. A rapid and convenient radioimmunoassay procedure for plasma or urine ouabain concentrations was developed using these antibodies. Competition between ouabain-(3)H tracer and unlabeled ouabain for specific antibody binding sites allowed the measurement of ouabain concentrations as low as 0.1 ng/ml or less without need for extraction procedures. The high association constants observed in these studies permit antibody reversal of established myocardial effects of ouabain. Both blockade and reversal of ouabain inhibition of canine myocardial microsomal Na(+), K(+)-activated ATPase by antibody were documented, suggesting a possible mechanism for reversal of cellular effects.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4260123      PMCID: PMC292297          DOI: 10.1172/JCI106956

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.

Authors:  R W Albers; G J Koval
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

2.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

Review 3.  The clinical pharmacology of digitalis glycosides: a review.

Authors:  J E Doherty
Journal:  Am J Med Sci       Date:  1968-06       Impact factor: 2.378

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  An improved method for measuring plasma and tissue concentrations of digitalis glycosides.

Authors:  J M Lowenstein; E M Corrill
Journal:  J Lab Clin Med       Date:  1966-06

6.  Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug.

Authors:  D A Lukas; R E Peterson
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

7.  Nucleotides. XLIX. The reduction of the adduct of periodate-oxidised adenosine-5' phosphate and methylamine.

Authors:  D M Brown; A P Read
Journal:  J Chem Soc Perkin 1       Date:  1965-09

8.  Binding of steroids to steroid-specific antibodies.

Authors:  P E Zimmering; S Lieberman; B F Erlanger
Journal:  Biochemistry       Date:  1967-01       Impact factor: 3.162

9.  Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.

Authors:  D G Grahame-Smith
Journal:  Br Med J       Date:  1969-02-01

10.  The measurement of digitoxin in human serum by radioimmunoassay.

Authors:  G C Oliver; B M Parker; D L Brasfield; C W Parker
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  6 in total

1.  The reactivation of the proscillaridin-inhibited membrane ATPase by specific antibodies.

Authors:  U R Kleeberg; G G Belz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.

Authors:  H R Ochs; T W Smith
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.

Authors:  K P Campbell; A Sharp; M Strom; S D Kahl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.

Authors:  T W Smith; B L Lloyd; N Spicer; E Haber
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  Studies on the localization of the cardiac glycoside receptor.

Authors:  T W Smith; H Wagner; J E Markis; M Young
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

6.  Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.

Authors:  H K Gold; T W Smith
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.